北米のインターベンショナル心臓医療機器市場(~2021)

◆英語タイトル:North America Interventional Cardiology Market Outlook to 2021
◆商品コード:GDMECR0388DB
◆発行会社(調査会社):GlobalData
◆発行日:2016年2月12日
◆ページ数:291
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD6,000 ⇒換算¥684,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD9,000 ⇒換算¥1,026,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

North America Interventional Cardiology Market Outlook to 2021
Summary

GlobalData’s new report, “North America Interventional Cardiology Market Outlook to 2021″, provides key market data on the North America Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments – Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and countries in the region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Interventional Cardiology market segments – Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters .
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Interventional Cardiology market.
- Global corporate-level profiles of key companies operating within the North America Interventional Cardiology market.
- Key players covered include Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Terumo Corporation and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Interventional Cardiology Devices Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 14
3 Interventional Cardiology Market, North America 18
3.1 Interventional Cardiology Market, North America, Revenue ($m), 2007-2021 18
3.2 Interventional Cardiology Market, North America, Category Comparison by Revenue ($m), 2007-2021 20
3.3 Interventional Cardiology Market, North America, Revenue ($m), 2007-2014 22
3.4 Interventional Cardiology Market, North America, Revenue ($m), 2014-2021 24
3.5 Interventional Cardiology Market, North America, Volume (Units), 2007-2021 26
3.6 Interventional Cardiology Market, North America, Volume (Units), 2007-2014 27
3.7 Interventional Cardiology Market, North America, Volume (Units), 2014-2021 29
3.8 Interventional Cardiology Market, North America, Company Share by Revenue ($m), 2014 31
4 Interventional Cardiology Market, Canada 33
4.1 Interventional Cardiology Market, Canada, Revenue ($m), 2007-2014 33
4.2 Interventional Cardiology Market, Canada, Revenue ($m), 2014-2021 35
4.2.1 Arteriotomy Closure Devices Market, Canada, Revenue ($m), by Segment, 2007-2014 37
4.2.2 Cardiac Catheters Market, Canada, Revenue ($m), by Segment, 2007-2014 39
4.2.3 Coronary Stents Market, Canada, Revenue ($m), by Segment, 2007-2014 41
4.2.4 Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), by Segment, 2007-2014 43
4.2.5 PTCA Balloons Market, Canada, Revenue ($m), by Segment, 2007-2014 45
4.2.6 Arteriotomy Closure Devices Market, Canada, Revenue ($m), by Segment, 2014-2021 47
4.2.7 Cardiac Catheters Market, Canada, Revenue ($m), by Segment, 2014-2021 49
4.2.8 Coronary Stents Market, Canada, Revenue ($m), by Segment, 2014-2021 51
4.2.9 Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), by Segment, 2014-2021 53
4.2.10 PTCA Balloons Market, Canada, Revenue ($m), by Segment, 2014-2021 55
4.3 Interventional Cardiology Market, Canada, Volume (Units), 2007-2014 57
4.4 Interventional Cardiology Market, Canada, Volume (Units), 2014-2021 59
4.4.1 Arteriotomy Closure Devices Market, Canada, Volume (Units), by Segment, 2007-2014 61
4.4.2 Cardiac Catheters Market, Canada, Volume (Units), by Segment, 2007-2014 63
4.4.3 Coronary Stents Market, Canada, Volume (Units), by Segment, 2007-2014 65
4.4.4 Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), by Segment, 2007-2014 67
4.4.5 PTCA Balloons Market, Canada, Volume (Units), by Segment, 2007-2014 69
4.4.6 Arteriotomy Closure Devices Market, Canada, Volume (Units), by Segment, 2014-2021 71
4.4.7 Cardiac Catheters Market, Canada, Volume (Units), by Segment, 2014-2021 73
4.4.8 Coronary Stents Market, Canada, Volume (Units), by Segment, 2014-2021 75
4.4.9 Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), by Segment, 2014-2021 77
4.4.10 PTCA Balloons Market, Canada, Volume (Units), by Segment, 2014-2021 79
4.5 Interventional Cardiology Market, Canada, Distribution Share by Revenue ($m), 2013-2014 81
4.6 Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2014 82
5 Interventional Cardiology Market, Mexico 84
5.1 Interventional Cardiology Market, Mexico, Revenue ($m), 2007-2014 84
5.2 Interventional Cardiology Market, Mexico, Revenue ($m), 2014-2021 86
5.2.1 Arteriotomy Closure Devices Market, Mexico, Revenue ($m), by Segment, 2007-2014 88
5.2.2 Cardiac Catheters Market, Mexico, Revenue ($m), by Segment, 2007-2014 90
5.2.3 Coronary Stents Market, Mexico, Revenue ($m), by Segment, 2007-2014 92
5.2.4 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), by Segment, 2007-2014 94
5.2.5 PTCA Balloons Market, Mexico, Revenue ($m), by Segment, 2007-2014 96
5.2.6 Arteriotomy Closure Devices Market, Mexico, Revenue ($m), by Segment, 2014-2021 98
5.2.7 Cardiac Catheters Market, Mexico, Revenue ($m), by Segment, 2014-2021 100
5.2.8 Coronary Stents Market, Mexico, Revenue ($m), by Segment, 2014-2021 102
5.2.9 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), by Segment, 2014-2021 104
5.2.10 PTCA Balloons Market, Mexico, Revenue ($m), by Segment, 2014-2021 106
5.3 Interventional Cardiology Market, Mexico, Volume (Units), 2007-2014 108
5.4 Interventional Cardiology Market, Mexico, Volume (Units), 2014-2021 110
5.4.1 Arteriotomy Closure Devices Market, Mexico, Volume (Units), by Segment, 2007-2014 112
5.4.2 Cardiac Catheters Market, Mexico, Volume (Units), by Segment, 2007-2014 114
5.4.3 Coronary Stents Market, Mexico, Volume (Units), by Segment, 2007-2014 116
5.4.4 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), by Segment, 2007-2014 118
5.4.5 PTCA Balloons Market, Mexico, Volume (Units), by Segment, 2007-2014 120
5.4.6 Arteriotomy Closure Devices Market, Mexico, Volume (Units), by Segment, 2014-2021 122
5.4.7 Cardiac Catheters Market, Mexico, Volume (Units), by Segment, 2014-2021 124
5.4.8 Coronary Stents Market, Mexico, Volume (Units), by Segment, 2014-2021 126
5.4.9 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), by Segment, 2014-2021 128
5.4.10 PTCA Balloons Market, Mexico, Volume (Units), by Segment, 2014-2021 130
5.5 Interventional Cardiology Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 132
5.6 Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), 2014 133
6 Interventional Cardiology Market, United States 135
6.1 Interventional Cardiology Market, United States, Revenue ($m), 2007-2014 135
6.2 Interventional Cardiology Market, United States, Revenue ($m), 2014-2021 137
6.2.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2007-2014 139
6.2.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2007-2014 141
6.2.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2007-2014 143
6.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2007-2014 145
6.2.5 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2007-2014 147
6.2.6 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2014-2021 149
6.2.7 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2014-2021 151
6.2.8 Coronary Stents Market, United States, Revenue ($m), by Segment, 2014-2021 153
6.2.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2014-2021 155
6.2.10 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2014-2021 157
6.3 Interventional Cardiology Market, United States, Volume (Units), 2007-2014 159
6.4 Interventional Cardiology Market, United States, Volume (Units), 2014-2021 161
6.4.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2007-2014 163
6.4.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2007-2014 165
6.4.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2007-2014 167
6.4.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2007-2014 169
6.4.5 PTCA Balloons Market, United States, Volume (Units), by Segment, 2007-2014 171
6.4.6 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2014-2021 173
6.4.7 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2014-2021 175
6.4.8 Coronary Stents Market, United States, Volume (Units), by Segment, 2014-2021 177
6.4.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2014-2021 179
6.4.10 PTCA Balloons Market, United States, Volume (Units), by Segment, 2014-2021 181
6.5 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2013-2014 183
6.6 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2014 184
7 Overview of Key Companies in North America Interventional Cardiology Market 186
7.1 Boston Scientific Corporation 186
7.1.1 Company Overview 186
7.2 Abbott Laboratories 186
7.2.1 Company Overview 186
7.3 Medtronic plc 186
7.3.1 Company Overview 186
7.4 Biotronik SE & Co. KG 187
7.4.1 Company Overview 187
7.5 Terumo Corporation 187
7.5.1 Company Overview 187
7.6 St. Jude Medical, Inc. 187
7.6.1 Company Overview 187
7.7 Edwards Lifesciences Corporation 187
7.7.1 Company Overview 187
7.8 Asahi Intecc Co., Ltd. 188
7.8.1 Company Overview 188
7.9 Volcano Corporation 188
7.9.1 Company Overview 188
7.10 Cook Medical Incorporated 188
7.10.1 Company Overview 188
7.11 Cordis Corporation 189
7.11.1 Company Overview 189
7.12 Cardinal Health, Inc. 189
7.12.1 Company Overview 189
8 Interventional Cardiology Market Pipeline Products 190
9 Recent Developments 194
9.1 Corporate Communications 194
9.1.1 Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors 194
9.1.2 Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer 194
9.1.3 Nov 09, 2015: AngioDynamics Announces Resignation of CFO and Appointment of Interim CFO 195
9.1.4 Nov 02, 2015: Data from Merz Aesthetics’ Post-Market Clinical Study of Xeomin(incobotulinumtoxinA) vs. Botox (onabotulinumtoxinA) for Glabellar Facial Lines Published in Dermatologic Surgery 195
9.1.5 Oct 08, 2015: SANUWAVE Health Releases dermaPACE Clinical Trial Top Line Data and Preliminary Data Analysis Results 197
9.1.6 Sep 09, 2015: LED Medical Diagnostics’ VELscope Vx Receives Regulatory Approval for Distribution in China 199
9.1.7 Aug 10, 2015: Transgenomic Establishes Clinical-Commercial Advisory Board to Help Optimize Use of Multiplexed ICE COLD-PCR in Oncology 200
9.1.8 Jul 15, 2015: Boston Scientific Elects Donna A. James To Board Of Directors 201
9.1.9 Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group 202
9.1.10 Jun 09, 2015: Transgenomic Expands Board of Directors and Executive Team 202
9.1.11 May 27, 2015: Boston Scientific Names Prof. John Mark Morgan as Senior Medical Director, Rhythm Management 204
9.1.12 May 26, 2015: IMRIS and Two Subsidiaries File for Chapter 11 Protection 204
9.1.13 Apr 13, 2015: Onxeo announces 6th positive DSMB recommendation for Livatag ReLive study in HCC 205
9.1.14 Mar 06, 2015: SurModics Announces New Board Chair 206
9.1.15 Mar 03, 2015: Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 207
9.1.16 Feb 24, 2015: Cardiva Medical Announces Appointment of John Russell, President and Chief Executive Officer 207
9.1.17 Feb 05, 2015: SurModics Announces Gerald B. Fischer’s Retirement from Board of Directors 208
9.2 Financial Announcements 208
9.2.1 Dec 18, 2015: BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack 208
9.2.2 Dec 18, 2015: Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping 210
9.2.3 Nov 12, 2015: Transgenomic Reports Third Quarter 2015 Financial Results 211
9.2.4 Nov 10, 2015: SurModics Reports Fourth Quarter Fiscal 2015 Results 214
9.2.5 Nov 09, 2015: Neovasc Reports Results for the Third Quarter of 2015 215
9.2.6 Nov 05, 2015: Hansen Medical Reports Third Quarter 2015 Results and Business Update 218
9.2.7 Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015 220
9.2.8 Oct 08, 2015: AngioDynamics to Present at the Jefferies 2015 Healthcare Conference 221
9.2.9 Oct 01, 2015: FDA Panel To Discuss On TransMedics PMA Application For OCS Heart Device 223
9.2.10 Sep 30, 2015: MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S. 224
9.2.11 Sep 09, 2015: Tandem Diabetes Care Announces FDA Approval of t:slim G4 Insulin Pump with CGM Integration 225
9.2.12 Aug 13, 2015: Transgenomic Reports Second Quarter 2015 Financial Results 227
9.2.13 Aug 06, 2015: Hansen Medical Reports Second Quarter 2015 Results and Business Update 230
9.2.14 Aug 06, 2015: Neovasc Reports Results for the Second Quarter of 2015 231
9.2.15 Aug 05, 2015: SurModics Reports Third Quarter Fiscal 2015 Results 235
9.2.16 Jul 23, 2015: Boston Scientific Announces Results For Second Quarter 2015 236
9.2.17 Jul 16, 2015: AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results 237
9.2.18 Jul 01, 2015: Aesculap Implant Systems Introduces the Modulift Vertebral Body Replacement System 239
9.2.19 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 241
9.2.20 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results 244
9.2.21 May 14, 2015: Transgenomic Reports First Quarter 2015 Financial Results 247
9.2.22 May 12, 2015: Neovasc Reports Results for the First Quarter of 2015 249
9.2.23 May 07, 2015: Hansen Medical Reports First Quarter 2015 Results and Business Update 251
9.2.24 Apr 30, 2015: SurModics Reports Second Quarter Fiscal 2015 Results 253
9.2.25 Apr 28, 2015: Boston Scientific Announces Results for First Quarter 2015 254
9.2.26 Apr 15, 2015: Transgenomic Provides Financial and Business Update 255
9.2.27 Apr 09, 2015: AngioDynamics Reports 2015 Third Quarter Financial Results 257
9.2.28 Mar 30, 2015: Neovasc Announces Results for the Fourth Quarter and Full Year Ended 2014 259
9.2.29 Mar 04, 2015: IMRIS Reports Fourth Quarter and Annual 2014 Financial Results 262
9.2.30 Feb 23, 2015: Hansen Medical Reports Fourth Quarter and Full-Year 2014 Results 263
9.2.31 Feb 04, 2015: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2014 266
9.2.32 Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results 267
9.2.33 Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine 269
9.3 Legal And Regulatory 270
9.3.1 Dec 03, 2015: FDA Lifts Warning Letters on AngioDynamics’ Facilities 270
9.3.2 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury’s Notice 2015-79 270
9.3.3 Nov 17, 2015: AngioDynamics Announces Resolution of FDA Warning Letter 270
9.3.4 Aug 20, 2015: Harvard’s Wyss Institute improves its sepsis therapeutic device 271
9.3.5 Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas 272
9.3.6 Feb 17, 2015: Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation 273
9.3.7 Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to “SubQ Stimulation” Procedures 274
9.3.8 Feb 04, 2015: Federal judge approves consent decree with Maquet Holding 274
9.4 Other Significant Developments 275
9.4.1 Jan 08, 2016: SurModics Provides Updated 2016 Guidance 275
9.4.2 Oct 15, 2015: New Swedish clinic treats first cancer patients with proton therapy 276
9.4.3 May 06, 2015: Boston Scientific Coyol, Costa Rica Facility Earns Shingo Award For Excellence In Manufacturing 278
9.4.4 May 01, 2015: Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 278
9.4.5 Feb 10, 2015: Premier awards specialty urology purchasing contract to Cook Medical 280
9.4.6 Feb 03, 2015: Boston Scientific Maple Grove Operations Named A 2014 “Best Plants” Winner 280
9.4.7 Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants 281
10 Appendix 283
10.1 Research Methodology 284
10.1.1 Coverage 284
10.1.2 Secondary Research 284
10.1.3 Primary Research 285
10.1.4 Market Modeling and Forecasting 286
10.1.5 Company Share Analysis 289
10.1.6 Distribution Share Analysis 290
10.2 Expert Panel 291
10.3 GlobalData Consulting 291
10.4 Contact Us 291
10.5 Disclaimer 291

1.1 List of Tables
Table 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 19
Table 2: Interventional Cardiology Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 21
Table 3: Interventional Cardiology Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 23
Table 4: Interventional Cardiology Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 25
Table 5: Interventional Cardiology Market, North America, Volume (Units), 2007-2021 26
Table 6: Interventional Cardiology Market, North America, Volume (Units), Historic, 2007-2014 28
Table 7: Interventional Cardiology Market, North America, Volume (Units), Forecast, 2014-2021 30
Table 8: Interventional Cardiology Market, North America, Company Share by Revenue ($m), USD Constant, 2014 32
Table 9: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 34
Table 10: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Table 11: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 38
Table 12: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 40
Table 13: Coronary Stents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 42
Table 14: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 44
Table 15: PTCA Balloons Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 46
Table 16: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 17: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 50
Table 18: Coronary Stents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 52
Table 19: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Table 20: PTCA Balloons Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 21: Interventional Cardiology Market, Canada, Volume (Units), Historic, 2007-2014 58
Table 22: Interventional Cardiology Market, Canada, Volume (Units), Forecast, 2014-2021 60
Table 23: Arteriotomy Closure Devices Market, Canada, Volume (Units), Historic, 2007-2014 62
Table 24: Cardiac Catheters Market, Canada, Volume (Units), Historic, 2007-2014 64
Table 25: Coronary Stents Market, Canada, Volume (Units), Historic, 2007-2014 66
Table 26: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), Historic, 2007-2014 68
Table 27: PTCA Balloons Market, Canada, Volume (Units), Historic, 2007-2014 70
Table 28: Arteriotomy Closure Devices Market, Canada, Volume (Units), Forecast, 2014-2021 72
Table 29: Cardiac Catheters Market, Canada, Volume (Units), Forecast, 2014-2021 74
Table 30: Coronary Stents Market, Canada, Volume (Units), Forecast, 2014-2021 76
Table 31: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), Forecast, 2014-2021 78
Table 32: PTCA Balloons Market, Canada, Volume (Units), Forecast, 2014-2021 80
Table 33: Interventional Cardiology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 81
Table 34: Interventional Cardiology Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 83
Table 35: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 36: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 87
Table 37: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 38: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 91
Table 39: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 93
Table 40: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 95
Table 41: PTCA Balloons Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 97
Table 42: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Table 43: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 101
Table 44: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 103
Table 45: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 105
Table 46: PTCA Balloons Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Table 47: Interventional Cardiology Market, Mexico, Volume (Units), Historic, 2007-2014 109
Table 48: Interventional Cardiology Market, Mexico, Volume (Units), Forecast, 2014-2021 111
Table 49: Arteriotomy Closure Devices Market, Mexico, Volume (Units), Historic, 2007-2014 113
Table 50: Cardiac Catheters Market, Mexico, Volume (Units), Historic, 2007-2014 115
Table 51: Coronary Stents Market, Mexico, Volume (Units), Historic, 2007-2014 117
Table 52: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), Historic, 2007-2014 119
Table 53: PTCA Balloons Market, Mexico, Volume (Units), Historic, 2007-2014 121
Table 54: Arteriotomy Closure Devices Market, Mexico, Volume (Units), Forecast, 2014-2021 123
Table 55: Cardiac Catheters Market, Mexico, Volume (Units), Forecast, 2014-2021 125
Table 56: Coronary Stents Market, Mexico, Volume (Units), Forecast, 2014-2021 127
Table 57: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), Forecast, 2014-2021 129
Table 58: PTCA Balloons Market, Mexico, Volume (Units), Forecast, 2014-2021 131
Table 59: Interventional Cardiology Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014 132
Table 60: Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014 134
Table 61: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 136
Table 62: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Table 63: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 140
Table 64: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 142
Table 65: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 144
Table 66: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 146
Table 67: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 148
Table 68: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 150
Table 69: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 152
Table 70: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Table 71: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Table 72: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 158
Table 73: Interventional Cardiology Market, United States, Volume (Units), Historic, 2007-2014 160
Table 74: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2014-2021 162
Table 75: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2007-2014 164
Table 76: Cardiac Catheters Market, United States, Volume (Units), Historic, 2007-2014 166
Table 77: Coronary Stents Market, United States, Volume (Units), Historic, 2007-2014 168
Table 78: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2007-2014 170
Table 79: PTCA Balloons Market, United States, Volume (Units), Historic, 2007-2014 172
Table 80: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2014-2021 174
Table 81: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2014-2021 176
Table 82: Coronary Stents Market, United States, Volume (Units), Forecast, 2014-2021 178
Table 83: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2014-2021 180
Table 84: PTCA Balloons Market, United States, Volume (Units), Forecast, 2014-2021 182
Table 85: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 183
Table 86: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2014 185
Table 87: Interventional Cardiology Market Pipeline Products 190
Table 88: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 286

1.2 List of Figures
Figure 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 18
Figure 2: Interventional Cardiology Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 20
Figure 3: Interventional Cardiology Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 22
Figure 4: Interventional Cardiology Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 24
Figure 5: Interventional Cardiology Market, North America, Volume (Units), 2007-2021 26
Figure 6: Interventional Cardiology Market, North America, Volume (Units), Historic, 2007-2014 27
Figure 7: Interventional Cardiology Market, North America, Volume (Units), Forecast, 2014-2021 29
Figure 8: Interventional Cardiology Market, North America, Company Share (%) 2014 31
Figure 9: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 33
Figure 10: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Figure 11: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 37
Figure 12: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 39
Figure 13: Coronary Stents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 41
Figure 14: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 43
Figure 15: PTCA Balloons Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 45
Figure 16: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 17: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 49
Figure 18: Coronary Stents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 51
Figure 19: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 53
Figure 20: PTCA Balloons Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 21: Interventional Cardiology Market, Canada, Volume (Units), Historic, 2007-2014 57
Figure 22: Interventional Cardiology Market, Canada, Volume (Units), Forecast, 2014-2021 59
Figure 23: Arteriotomy Closure Devices Market, Canada, Volume (Units), Historic, 2007-2014 61
Figure 24: Cardiac Catheters Market, Canada, Volume (Units), Historic, 2007-2014 63
Figure 25: Coronary Stents Market, Canada, Volume (Units), Historic, 2007-2014 65
Figure 26: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), Historic, 2007-2014 67
Figure 27: PTCA Balloons Market, Canada, Volume (Units), Historic, 2007-2014 69
Figure 28: Arteriotomy Closure Devices Market, Canada, Volume (Units), Forecast, 2014-2021 71
Figure 29: Cardiac Catheters Market, Canada, Volume (Units), Forecast, 2014-2021 73
Figure 30: Coronary Stents Market, Canada, Volume (Units), Forecast, 2014-2021 75
Figure 31: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), Forecast, 2014-2021 77
Figure 32: PTCA Balloons Market, Canada, Volume (Units), Forecast, 2014-2021 79
Figure 33: Interventional Cardiology Market, Canada, Company Share (%) 2014 82
Figure 34: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 35: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 86
Figure 36: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 88
Figure 37: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 90
Figure 38: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 92
Figure 39: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 94
Figure 40: PTCA Balloons Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 96
Figure 41: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Figure 42: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 100
Figure 43: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 102
Figure 44: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 104
Figure 45: PTCA Balloons Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 106
Figure 46: Interventional Cardiology Market, Mexico, Volume (Units), Historic, 2007-2014 108
Figure 47: Interventional Cardiology Market, Mexico, Volume (Units), Forecast, 2014-2021 110
Figure 48: Arteriotomy Closure Devices Market, Mexico, Volume (Units), Historic, 2007-2014 112
Figure 49: Cardiac Catheters Market, Mexico, Volume (Units), Historic, 2007-2014 114
Figure 50: Coronary Stents Market, Mexico, Volume (Units), Historic, 2007-2014 116
Figure 51: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), Historic, 2007-2014 118
Figure 52: PTCA Balloons Market, Mexico, Volume (Units), Historic, 2007-2014 120
Figure 53: Arteriotomy Closure Devices Market, Mexico, Volume (Units), Forecast, 2014-2021 122
Figure 54: Cardiac Catheters Market, Mexico, Volume (Units), Forecast, 2014-2021 124
Figure 55: Coronary Stents Market, Mexico, Volume (Units), Forecast, 2014-2021 126
Figure 56: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), Forecast, 2014-2021 128
Figure 57: PTCA Balloons Market, Mexico, Volume (Units), Forecast, 2014-2021 130
Figure 58: Interventional Cardiology Market, Mexico, Company Share (%) 2014 133
Figure 59: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 135
Figure 60: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Figure 61: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 139
Figure 62: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 141
Figure 63: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 143
Figure 64: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 145
Figure 65: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 147
Figure 66: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 149
Figure 67: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 151
Figure 68: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 153
Figure 69: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Figure 70: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 157
Figure 71: Interventional Cardiology Market, United States, Volume (Units), Historic, 2007-2014 159
Figure 72: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2014-2021 161
Figure 73: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2007-2014 163
Figure 74: Cardiac Catheters Market, United States, Volume (Units), Historic, 2007-2014 165
Figure 75: Coronary Stents Market, United States, Volume (Units), Historic, 2007-2014 167
Figure 76: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2007-2014 169
Figure 77: PTCA Balloons Market, United States, Volume (Units), Historic, 2007-2014 171
Figure 78: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2014-2021 173
Figure 79: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2014-2021 175
Figure 80: Coronary Stents Market, United States, Volume (Units), Forecast, 2014-2021 177
Figure 81: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2014-2021 179
Figure 82: PTCA Balloons Market, United States, Volume (Units), Forecast, 2014-2021 181
Figure 83: Interventional Cardiology Market, United States, Company Share (%) 2014 184
Figure 84: GlobalData Epidemiology-Based Forecasting Model 288
Figure 85: GlobalData Capital Equipment-Based Forecasting Model 289
Figure 86: Primary Interviews by Participant Type (%) 290

【掲載企業】

Boston Scientific Corporation
Abbott Laboratories
Medtronic plc
Biotronik SE & Co. KG
Terumo Corporation
St. Jude Medical, Inc.
Edwards Lifesciences Corporation
Asahi Intecc Co., Ltd.
Volcano Corporation
Cook Medical Incorporated
Cordis Corporation
Cardinal Health, Inc.

★調査レポート[北米のインターベンショナル心臓医療機器市場(~2021)]販売に関する免責事項
★調査レポート[北米のインターベンショナル心臓医療機器市場(~2021)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆